MD : NYSE : Health Care
$60.08 up 0.43 | 0.72%
Today's Range: 59.4 - 60.17
Avg. Daily Volume: 1041800.0
06/28/17 - 11:57 AM ET

Financial Analysis

MEDNAX INC's gross profit margin for the first quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. MEDNAX INC has strong liquidity. Currently, the Quick Ratio is 1.65 which shows the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.

During the same period, stockholders' equity ("net worth") has increased by 12.27% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit

Income Statement Q1 FY17 Q1 FY16
Net Sales ($mil)835.6752.62
EBITDA ($mil)131.65143.82
EBIT ($mil)106.04124.23
Net Income ($mil)54.6967.9

Balance Sheet Q1 FY17 Q1 FY16
Cash & Equiv. ($mil)52.9864.28
Total Assets ($mil)5424.894636.29
Total Debt ($mil)1902.351442.7
Equity ($mil)2762.472460.41

Profitability Q1 FY17 Q1 FY16
Gross Profit Margin28.1731.06
EBITDA Margin15.7519.1
Operating Margin12.6916.51
Sales Turnover0.60.62
Return on Assets5.747.23
Return on Equity11.2813.63
Debt Q1 FY17 Q1 FY16
Current Ratio1.711.76
Interest Expense17.7514.46
Interest Coverage5.978.59

Share Data Q1 FY17 Q1 FY16
Shares outstanding (mil)92.992.92
Div / share0.00.0
Book value / share29.7326.48
Institutional Own % n/a n/a
Avg Daily Volume989291.0688893.0


HOLD. This stock's P/E ratio indicates a discount compared to an average of 24.51 for the Health Care Providers & Services industry and a discount compared to the S&P 500 average of 25.75. To use another comparison, its price-to-book ratio of 2.00 indicates a discount versus the S&P 500 average of 3.09 and a significant discount versus the industry average of 3.56. The price-to-sales ratio is below the S&P 500 average, but well above the industry average. Upon assessment of these and other key valuation criteria, MEDNAX INC proves to trade at a discount to investment alternatives within the industry.

1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
MD 17.74 Peers 24.51   MD 12.27 Peers 14.23

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

MD is trading at a significant discount to its peers.


Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

MD is trading at a discount to its peers.

1 2 3 4 5
premium   discount
  Price to
1 2 3 4 5
premium   discount
MD 14.90 Peers 17.26   MD 5.91 Peers 1.32

Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.

MD is trading at a valuation on par with its peers.


Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

MD trades at a significant premium to its peers.

1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
MD 2.00 Peers 3.56   MD -6.41 Peers 16.90

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

MD is trading at a significant discount to its peers.


Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, MD is expected to significantly trail its peers on the basis of its earnings growth rate.

1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
MD 1.70 Peers 0.93   MD 12.88 Peers 10.31

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

MD is trading at a significant premium to its industry.


Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

MD has a sales growth rate that exceeds its peers.



Latest Stock Upgrades/Downgrades